France Hosts Israeli-Palestinian Civil Society Appeal to Revive Two-State Solution Ahead of G7 Summit 
Xi’s North Korea Visit Strengthens Ties and Elevates Kim Jong Un’s Global Standing 
US-Iran Peace Deal Nears as Tehran and Pakistan Signal Breakthrough 
US Plans NATO Force Reduction in Europe Amid Defense Burden Dispute 
Peru Election 2026: Fujimori Holds Narrow Lead as Contested Votes Face Review 
IMF Advances Ukraine Loan Program, Clears $690M Disbursement 
Taiwan Launches Intelligence Tip Website Targeting Chinese Informants 
U.S.-Iran Peace Framework Nears as Strait of Hormuz Reopening Takes Center Stage 
North Korea Slams U.S. Missile Sale to South Korea, Warns of Rising Regional Tensions 
South Korea Ex-President Yoon Suk Yeol Sentenced to 30 Years Over Martial Law Plot 
Viktor Orban Re-Elected as Fidesz Leader After Election Defeat 
US Appeals Court Keeps Trump’s 10% Global Tariff in Effect During Ongoing Legal Battle 
Trump Says Iran Peace Deal Near as Markets Rally and Oil Prices Fall 
DOJ Sues Virginia Over Law Enforcement Mask Ban 
South Korea Ballot Shortage Sparks Protests, Election Fraud Claims, and Calls for Rerun 
JCPOA Nuclear Deal Explained as U.S. Nears Potential New Iran Peace Agreement 
Trump Names James McDonald as New SDNY U.S. Attorney 
Former President Donald Trump’s administration was highly criticized for their response to the COVID-19 pandemic with reports surfacing of conflicts between experts and administration officials behind the scenes.
A new report reveals the Trump administration had given $1.3 billion to a company producing syringes for the vaccines, but no syringes were produced.
Despite having millions of COVID-19 vaccine doses already administered recently, a report has surfaced that the Trump administration gave a $1.3 billion contract to ApiJect Systems Corp. to make the syringes needed to administer the vaccines. However, no syringes have been made, and the company’s supposed plans to establish a factory with 650 jobs open remains to be seen. The syringes also have yet to gain approval from the federal government before it could be produced as well.
Nevertheless, the need for ApiJect’s syringes has now declined especially as millions of Americans have already been vaccinated. This now leaves the contracts and federal loans in the air.
In a statement to NBC News, ApiJect said it “is working with several vaccine pharmaceutical companies to conduct the testing and regulatory reviews of the COVID-19 vaccines in the ApiJect syringe.”
A spokesperson for Pfizer, however, said that even if the ApiJect syringes received all the approvals from the federal government, it would not affect their output or their process. Moderna and Johnson & Johnson did not comment.
In other news, Trump has touted the wall closing off the southern border and keeping migrants from crossing as one of his campaign pledges, an effort that Joe Biden shut down as soon as he took office. However, as the Biden administration tackles the influx of migrants seeking to make it to the US, US Border Patrol officials have often discovered ladders left alongside the wall. The officials have also had to call for assistance in Hidalgo, Texas, to clear out the discarded ladders that migrants used to scale the wall.
According to local artist and activist Scott Lowry, the use of ladders to climb the wall and cross the border proves the uselessness of the wall that Trump had planned. “Unlike the wall, these ladders are functional,” said Lowry.
